Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Allan

Showing results (141-150 of 532) with videos related to

Pageof 54
Sort By:
Histopathology|March 5, 2015
Aneusomy detected by fluorescence in-situ hybridization has high positive predictive value for Barrett's dysplasiaEuan A G Allan, Roy Miller, James J Going
Magnetic Resonance in Medicine|February 4, 2005
Ventilation-synchronous magnetic resonance microscopy of pulmonary structure and ventilation in miceBen T Chen, Alexander T Yordanov, G Allan Johnson
British Journal of Pharmacology|January 1, 1980
Inhibition of thromboxane A2 biosynthesis in human platelets by burimamideG Allan, K E Eakins, P S Kulkarni, et al.
Neurochemistry International|February 1, 1997
Bioactive lipids in excitatory neurotransmission and neuronal plasticityN G Bazan, M G Packard, L Teather, et al.
Journal of Palliative Medicine|April 17, 2012
Staff perceptions of end-of-life care following implementation of the liverpool care pathway for the dying patient in the acute care setting: a New Zealand perspectiveJean B Clark, Karen Sheward, Bridget Marshall, et al.
Postgraduate Medical Journal|July 1, 1985
Acute pancreatitis in association with small cell lung carcinoma: potential pitfall in diagnosis and managementS G Allan, N Bundred, O Eremin, et al.
Journal of Neurotrauma|October 1, 1995
Mediators of injury in neurotrauma: intracellular signal transduction and gene expressionN G Bazan, E B Rodriguez de Turco, G Allan
British Journal of Pharmacology|June 1, 1986
BW A256C, a chemically novel class 1 antiarrhythmic agent. A comparison of in vitro and in vivo activity with other class 1 antiarrhythmic agentsG Allan, S Donoghue, M J Follenfant, et al.
European Journal of Pharmacology|November 1, 1975
Selective impairment of atrioventricular conduction by 2-(2-pyridyl)-ethylamine and 2-(2-thiazolyl)-ethylamine, two histamine H1-receptor agonistsR Levi, C R Ganellin, G Allan, et al.
British Journal of Pharmacology|June 1, 1992
The effects of combined angiotensin converting enzyme inhibition and beta-adrenoceptor blockade on plasma renin activity in anaesthetized dogsD Cambridge, M V Whiting, L J Butterfield, et al.
Pageof 54

Showing results (141-150 of 532) with videos related to

Sort By:
Pageof 54
Histopathology|March 5, 2015
Aneusomy detected by fluorescence in-situ hybridization has high positive predictive value for Barrett's dysplasiaEuan A G Allan, Roy Miller, James J Going
Magnetic Resonance in Medicine|February 4, 2005
Ventilation-synchronous magnetic resonance microscopy of pulmonary structure and ventilation in miceBen T Chen, Alexander T Yordanov, G Allan Johnson
British Journal of Pharmacology|January 1, 1980
Inhibition of thromboxane A2 biosynthesis in human platelets by burimamideG Allan, K E Eakins, P S Kulkarni, et al.
Neurochemistry International|February 1, 1997
Bioactive lipids in excitatory neurotransmission and neuronal plasticityN G Bazan, M G Packard, L Teather, et al.
Journal of Palliative Medicine|April 17, 2012
Staff perceptions of end-of-life care following implementation of the liverpool care pathway for the dying patient in the acute care setting: a New Zealand perspectiveJean B Clark, Karen Sheward, Bridget Marshall, et al.
Postgraduate Medical Journal|July 1, 1985
Acute pancreatitis in association with small cell lung carcinoma: potential pitfall in diagnosis and managementS G Allan, N Bundred, O Eremin, et al.
Journal of Neurotrauma|October 1, 1995
Mediators of injury in neurotrauma: intracellular signal transduction and gene expressionN G Bazan, E B Rodriguez de Turco, G Allan
British Journal of Pharmacology|June 1, 1986
BW A256C, a chemically novel class 1 antiarrhythmic agent. A comparison of in vitro and in vivo activity with other class 1 antiarrhythmic agentsG Allan, S Donoghue, M J Follenfant, et al.
European Journal of Pharmacology|November 1, 1975
Selective impairment of atrioventricular conduction by 2-(2-pyridyl)-ethylamine and 2-(2-thiazolyl)-ethylamine, two histamine H1-receptor agonistsR Levi, C R Ganellin, G Allan, et al.
British Journal of Pharmacology|June 1, 1992
The effects of combined angiotensin converting enzyme inhibition and beta-adrenoceptor blockade on plasma renin activity in anaesthetized dogsD Cambridge, M V Whiting, L J Butterfield, et al.
Pageof 54